Overview

AGA Clinical Trials is a multispecialty clinical research unit with sites in South Florida and South America and 12 full-time clinical research coordinators with more than 120 years of combined experience in metabolic, cardiovascular, dermatologic, neurological, men's and women's health, gastrointestinal, cosmetics, devices, nutraceuticals and vaccine studies.

We are proud to announce to our sponsors/CROs that we opened a site in Ecuador, South America, in 2011, currently conducting trials for phases 2 to 4. The facility offers centralized enrollment, reduced costs compared with trials conducted in the US (30-35%), bilingual personnel, a dollarized country, regulatory times of < 60 days, and a large pool of patients (9,700) who are open to volunteer for clinical trials. Recruitment is supported from our board-certified physicians in different areas from two of the largest public hospitals in South America.

Our facilities are fully functional, complete and ready for a site-qualification visit anytime you wish to come.

Research Experience

Aga Clinical Trials is proud to be part of Centers for Diversity in Clinical Research providing sponsors with a largest pool of minority Hispanic volunteers in southeastern U.S.

Aga Clinical Trials has been selected as a preferred partner by PPD, Parexel, IQVIA, and Covance.

We are part of hyperCORE International network of sites, of which our VP is the current CMO.

Previous research experience has been recognized in areas as metabolic, cardiovascular, pain management, vaccines, biosimilars, women’s health, dermatology, devices, and nutraceuticals among others.

Treatment Areas

Facility Description

Our sites have 6 Patient exam rooms, onsite laboratories with refrigerated and regular centrifuges, gram stain capabilities, two ECG machines, a crash cart, a defibrillator, oxygen, emergency medication, a secured long-term storage area, a temperature-controlled, camera- controlled drug room and refrigerator, -20° and -80° freezers, Class II A2 BSC,RT-PCR Onsite, bolted, double-locked storage closets, a calibrated scale, calibrated blood pressure cuffs, vestibular function test capabilities, and ultrasound and pulmonary function testing.

Comfortable and very friendly environment to accommodate up to seven CRA's during monitoring visits; office closes late so after-hours and Saturday site checks are readily available.

Site has overnight stay capabilities with 10 beds and extended PK, first-in-human, MAD/SAD, PK/PD, Toxicology, Special Populations, experience for phase 1 trials in pediatric and adult populations.

Easy access by public transportation, Metro, MIA and FLL airport. Free parking.

Investigator Experience

Dario Altamirano, DO

Board certified in family practice and emergency medicine. Principal investigator for 163 multi-specialty phase 1 to 4 trials to date in pharmaceuticals, devices, biosimilars, nutraceuticals, vaccines and cosmetics, Opinion Leader In COVID 19 Dx, Treatment and Prevention.

Staff Expertise

Ximena Graber CPI, CCRP
CEO, lead coordinator, 16 years of experience

Roberto Aguirre CPI, CCRP
VP/global research director, lead CRC, 15 years of experience

Dario Altamirando, DO
Principal investigator, 13 years of experience

Paola Diaz
Regulatory specialist, 10 years of experience

Diana Arango
Lead CRC, 13 years of experience

Barbara Colmenares
Lead lab tech specialist, backup CRC, 3 years of experience

Jenny Daza
Lead, blinded personnel

Ana Gaitan
CRC, lab tech specialist, backup CRC, 5 years of experience

Iran Mateu
Recruitment specialist, 4 years of experience

Patient Demographics

Access to a very extensive and diverse database of approximately 13,500 subjects with a variety of medical indications.

Our demography is divided in 65 percent bilingual Hispanic, 20 percent African American, 10 percent Caucasian, 5 percent Asian; office provides immigration services, which eases recruiting of any type of naive trials.

Other Information

Only central IRB

PBMC Capabilities

MRI-PDFF Capabilities

PET SCANS